Cargando…

Testicular recurrence of oligometastatic prostatic adenocarcinoma after 22 years of androgen deprivation therapy

Testicular metastasis of carcinoma is a rare condition. We report a rare case of right testicular metastasis of prostatic adenocarcinoma in an 84 years old patient, after more than 20 years of controlled disease under androgen deprivation therapy. Follow-up consisted in PSA monitoring, clinical exam...

Descripción completa

Detalles Bibliográficos
Autores principales: Fortier, Alexa, Mokadem, Seif, Cornet, Emlyn, Cornu, Jean-Nicolas, Sabourin, Jean-Christophe, Pfister, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058943/
https://www.ncbi.nlm.nih.gov/pubmed/35509726
http://dx.doi.org/10.1016/j.eucr.2022.102055
_version_ 1784698221182844928
author Fortier, Alexa
Mokadem, Seif
Cornet, Emlyn
Cornu, Jean-Nicolas
Sabourin, Jean-Christophe
Pfister, Christian
author_facet Fortier, Alexa
Mokadem, Seif
Cornet, Emlyn
Cornu, Jean-Nicolas
Sabourin, Jean-Christophe
Pfister, Christian
author_sort Fortier, Alexa
collection PubMed
description Testicular metastasis of carcinoma is a rare condition. We report a rare case of right testicular metastasis of prostatic adenocarcinoma in an 84 years old patient, after more than 20 years of controlled disease under androgen deprivation therapy. Follow-up consisted in PSA monitoring, clinical examination, CT and bone scan. Biological recurrence, right testicular mass and finally right total orchiectomy allowed the diagnosis of a right testicular metastasis. PSA monitoring and clinical surveillance are important tools for diagnosing metastatic localisations.
format Online
Article
Text
id pubmed-9058943
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90589432022-05-03 Testicular recurrence of oligometastatic prostatic adenocarcinoma after 22 years of androgen deprivation therapy Fortier, Alexa Mokadem, Seif Cornet, Emlyn Cornu, Jean-Nicolas Sabourin, Jean-Christophe Pfister, Christian Urol Case Rep Oncology Testicular metastasis of carcinoma is a rare condition. We report a rare case of right testicular metastasis of prostatic adenocarcinoma in an 84 years old patient, after more than 20 years of controlled disease under androgen deprivation therapy. Follow-up consisted in PSA monitoring, clinical examination, CT and bone scan. Biological recurrence, right testicular mass and finally right total orchiectomy allowed the diagnosis of a right testicular metastasis. PSA monitoring and clinical surveillance are important tools for diagnosing metastatic localisations. Elsevier 2022-03-17 /pmc/articles/PMC9058943/ /pubmed/35509726 http://dx.doi.org/10.1016/j.eucr.2022.102055 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Oncology
Fortier, Alexa
Mokadem, Seif
Cornet, Emlyn
Cornu, Jean-Nicolas
Sabourin, Jean-Christophe
Pfister, Christian
Testicular recurrence of oligometastatic prostatic adenocarcinoma after 22 years of androgen deprivation therapy
title Testicular recurrence of oligometastatic prostatic adenocarcinoma after 22 years of androgen deprivation therapy
title_full Testicular recurrence of oligometastatic prostatic adenocarcinoma after 22 years of androgen deprivation therapy
title_fullStr Testicular recurrence of oligometastatic prostatic adenocarcinoma after 22 years of androgen deprivation therapy
title_full_unstemmed Testicular recurrence of oligometastatic prostatic adenocarcinoma after 22 years of androgen deprivation therapy
title_short Testicular recurrence of oligometastatic prostatic adenocarcinoma after 22 years of androgen deprivation therapy
title_sort testicular recurrence of oligometastatic prostatic adenocarcinoma after 22 years of androgen deprivation therapy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058943/
https://www.ncbi.nlm.nih.gov/pubmed/35509726
http://dx.doi.org/10.1016/j.eucr.2022.102055
work_keys_str_mv AT fortieralexa testicularrecurrenceofoligometastaticprostaticadenocarcinomaafter22yearsofandrogendeprivationtherapy
AT mokademseif testicularrecurrenceofoligometastaticprostaticadenocarcinomaafter22yearsofandrogendeprivationtherapy
AT cornetemlyn testicularrecurrenceofoligometastaticprostaticadenocarcinomaafter22yearsofandrogendeprivationtherapy
AT cornujeannicolas testicularrecurrenceofoligometastaticprostaticadenocarcinomaafter22yearsofandrogendeprivationtherapy
AT sabourinjeanchristophe testicularrecurrenceofoligometastaticprostaticadenocarcinomaafter22yearsofandrogendeprivationtherapy
AT pfisterchristian testicularrecurrenceofoligometastaticprostaticadenocarcinomaafter22yearsofandrogendeprivationtherapy